The Latest Breaking News from diabetes

Research undertaken in South Korea shows that taking pioglitazone may help reduce the onset of dementia

It’s not a failure of collective willpower that’s jeopardising our health, but a diet of bad food that’s culturally familiar, low in nutrition and super available

Researchers at Cedars-Smidt Sinai's Heart Institute have confirmed that persons who have had COVID-19 have a higher risk of developing new-onset diabetes, which is the leading cause of cardiovascular disease. Read further on Dynamite News:

A keto-style diet blended with traditional Indigenous ways of eating may be key to helping Aboriginal communities manage type 2 diabetes, researchers say.

Hidden fat makes up around one tenth of all the fat stored in the body, but too much can increase your risk of heart disease, diabetes and cancer.

'I already don't have a lot left each month,' said one disabled tenant. 'It's going to mean cutting back on food, even though I've got Type 2 diabetes and I have to be careful what I eat'

Sales of the buzzy new class of diabetes drugs have skyrocketed more than 2,000% in 4 years, data from Komodo Health shows.

The risk is heightened even in mothers who did not experience gestational diabetes

Endocrine-disrupting chemicals (EDCs) in plastics may raise the risk of diabetes in women, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism. Read further on Dynamite News:

According to a study published online in the journal BMJ Open Diabetes Research & Care, people who live with a partner have a higher possibility of being healthy in terms of keeping lower blood sugar levels, regardless of how amicable or combative their relationship is. Read further on Dynamite News:

Prominent pharma player Novo Nordisk (NVO) posted solid revenue and earnings growth in fiscal 2022. The company’s long-term growth is expected to be spearheaded by its immensely popular GLP-1 drug Wegovy. Given the potential of its current portfolio of drugs and drugs under research, investing in this stock could be…